Life Sciences

Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.

Our Latest thinking

The Unstoppables: Success stories of the world’s most inspiring entrepreneurs

The latest EY entrepreneurship documentary, “The Unstoppables 3,” features inspiring professional and personal entrepreneur success stories. Read more.

Stasia Mitchell

Pulse of the MedTech Industry report 2024

2024 EY MedTech report on dealmaking, financing, and state of the industry, with insights on growth and commercial strategies, AI, consumer and more.

Jim Welch + 2

Why licensing deals are a powerful source of growth in life sciences

Innovation is key in Life Sciences. In response to challenges, pharmaceutical companies increasingly turn to external innovation, leveraging licensing deals. Learn more.

Dr. Markus von Minden + 1

Beyond Borders: EY Biotechnology Report 2024

New EY biotechnology report with deal, financing and other data, plus insights on AI, GLP-1 drugs, oncology breakthroughs, the VC lens and much more.

How will you respond to clinicians sounding the alarm on unsustainable care delivery models?

The EY Global Voices in Health Care Study finds health systems must embrace sustainable care delivery models to address workforce challenges. Learn more.

What going digital means for Takeda

Find out how Takeda Business Solutions (TBS) fast-tracked its digitalization evolution.

Helmut Rattenberger + 1

How you can create value in an intelligent health ecosystem

The intelligent health ecosystem will provide smarter insights and personalized health care experiences to patients, anytime and anywhere.

Pamela Spence

How ecosystem participation drives more value for life sciences deals

Biopharmas need to embrace strategic partnerships that share risk and reward to achieve their growth ambitions. Learn more.

Subin Baral

How to account for outcome-based payment arrangements in life sciences

The use of outcome-based payment arrangements in the life sciences sector is growing in many jurisdictions, especially across Europe.

EY Global

    Life Sciences 4.0

    When the human body is the biggest data platform, who will capture value?

    Learn more

    How EY can help

    Linda Hill

    EY Global and Americas Consumer and Health Leader
    Strategic leader focused on innovation. Collaborative team builder. Champion for audit quality. Client-centric problem solver. Avid reader. Ambitious hiker. Occasional middle school sports coach.
    St. Louis, USA

    Daniel Mathews

    EY Global Life Sciences Leader; EY EMEIA Life Sciences Market Lead
    Passionate about driving health outcomes. Focused on making pharmaceutical innovations affordable and easily accessible to everyone.
    London, GBR
    Contact us
    Like what you’ve seen? Get in touch to learn more.

    EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.